NBY logo

NovaBay Pharmaceuticals (NBY) Operating Profit

Annual Operating Profit

-$5.00 M
+$2.68 M+34.86%

December 1, 2023

Summary

Performance

1-Year Change

+34.86%

3-Year Change

+22.14%

5-Year Change

+36.44%

15-Year Change

+31.57%

NBY Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

76.05%
NBY annual operating income is higher than 76.05% of companies in Healthcare sector

High & Low

All-time High

$2.74 M
NBY annual operating income is currently -282.59% below its historical high of $2.74 million

3-Year Low

-$8.86 M

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2023
NBY previous annual earnings announcement was published on Dec 1, 2023

Next Annual Earnings Report Date

N/A
NBY next annual earnings announcement has not yet been scheduled

OtherNBYprofitabilitymetrics:

Annual Operating Margin

-33.97%
NBY annual operating profit margin is -33.97%

Annual Revenue

$14.73 M
NBY annual revenue is $14.73 million

Annual Net Income

-$9.64 M
NBY annual net profit is -$9.64 million

Annual EPS

-$138.60
NBY annual earnings per share is -$138.60

Quarterly Operating Profit

-$1.06 M
-$8000.00-0.76%

September 1, 2024

Summary

Performance

3-Month Change

-0.76%

1-Year Change

-52.01%

3-Year Change

-0.95%

5-Year Change

-0.95%

NBY Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

73.75%
NBY quarterly operating income is higher than 73.75% of companies in Healthcare sector

High & Low

All-time High

$3.44 M
NBY quarterly operating income is currently -130.89% below its historical high of $3.44 million

3-Year Low

-$3.19 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
NBY previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

N/A
NBY next earnings announcement has not yet been scheduled

OtherNBYprofitabilitymetrics:

Quarterly Operating Margin

-43.47%
NBY quarterly operating profit margin is -43.47%

Quarterly Revenue

$2.44 M
NBY quarterly revenue is $2.44 million

Quarterly Net Income

-$1.21 M
NBY quarterly net profit is -$1.21 million

Quarterly EPS

-$0.60
NBY quarterly earnings per share is -$0.60

TTM Operating Profit

-$5.59 M
-$363.00 K-6.94%

September 1, 2024

Summary

Performance

3-Month Change

-6.94%

1-Year Change

+3.27%

3-Year Change

-0.94%

5-Year Change

-0.94%

NBY TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

74.94%
NBY TTM operating income is higher than 74.94% of companies in Healthcare sector

High & Low

All-time High

$2.74 M
NBY TTM operating income is currently -304.24% below its historical high of $2.74 million

3-Year Low

-$10.02 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
NBY previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

N/A
NBY next earnings announcement has not yet been scheduled

OtherNBYprofitabilitymetrics:

Annual Operating Margin

-33.97%
NBY annual operating profit margin is -33.97%

TTM Revenue

$13.84 M
NBY TTM revenue is $13.84 million

TTM Net Income

-$10.12 M
NBY TTM net profit is -$10.12 million

TTM EPS

-$35.80
NBY TTM earnings per share is -$35.80

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

Annual Operating Profit

-$5.00 M
NBY annual operating income is -$5.00 million

Annual Gross Profit

$7.89 M
NBY annual gross profit is $7.89 million

Annual Operating Expenses

$12.90 M
NBY annual total operating expenses is $12.90 million

NBY Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+34.9%-52.0%+3.3%
3 y3 years+22.1%-0.9%-0.9%
5 y5 years+36.4%-0.9%-0.9%

NBY Operating Profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+43.5%-132.2%+66.8%-11.8%+44.1%
5 y5-yearat high+46.8%-132.2%+66.8%-11.8%+44.1%
alltimeall time-282.6%+76.3%-130.9%+83.1%-304.2%+73.5%

NovaBay Pharmaceuticals Operating Profit History

DateAnnualQuarterlyTTM
Sep 2024
-
-$1.06 M(+0.8%)
-$5.59 M(+6.9%)
Jun 2024
-
-$1.05 M(-33.0%)
-$5.23 M(+0.0%)
Mar 2024
-
-$1.57 M(-17.7%)
-$5.23 M(+4.5%)
Dec 2023
-$5.00 M(-34.9%)
-$1.91 M(+173.5%)
-$5.00 M(-13.5%)
Sep 2023
-
-$698.00 K(-33.6%)
-$5.78 M(+4.3%)
Jun 2023
-
-$1.05 M(-21.9%)
-$5.54 M(-16.6%)
Mar 2023
-
-$1.34 M(-50.0%)
-$6.64 M(-13.5%)
Dec 2022
-$7.68 M(-13.3%)
-$2.69 M(+488.4%)
-$7.68 M(-6.2%)
Sep 2022
-
-$457.00 K(-78.8%)
-$8.19 M(-18.3%)
Jun 2022
-
-$2.15 M(-9.7%)
-$10.02 M(+3.0%)
Mar 2022
-
-$2.38 M(-25.4%)
-$9.72 M(+9.7%)
Dec 2021
-$8.86 M(+37.9%)
-$3.19 M(+39.5%)
-$8.86 M(+19.3%)
Sep 2021
-
-$2.29 M(+23.1%)
-$7.43 M(+3.2%)
Jun 2021
-
-$1.86 M(+22.3%)
-$7.20 M(+12.3%)
Mar 2021
-
-$1.52 M(-13.5%)
-$6.41 M(-0.2%)
Dec 2020
-$6.43 M(-31.6%)
-$1.76 M(-14.7%)
-$6.43 M(-7.0%)
Sep 2020
-
-$2.06 M(+92.5%)
-$6.91 M(+5.3%)
Jun 2020
-
-$1.07 M(-30.2%)
-$6.56 M(-4.5%)
Mar 2020
-
-$1.53 M(-31.4%)
-$6.86 M(-27.0%)
Dec 2019
-$9.40 M(+19.4%)
-$2.24 M(+30.7%)
-$9.40 M(+7.1%)
Sep 2019
-
-$1.71 M(+24.1%)
-$8.77 M(-1.1%)
Jun 2019
-
-$1.38 M(-66.1%)
-$8.87 M(-7.4%)
Mar 2019
-
-$4.07 M(+152.7%)
-$9.57 M(+21.6%)
Dec 2018
-$7.87 M(+7.7%)
-$1.61 M(-10.9%)
-$7.87 M(+34.1%)
Sep 2018
-
-$1.81 M(-13.2%)
-$5.87 M(-5.8%)
Jun 2018
-
-$2.08 M(-12.0%)
-$6.23 M(+5.5%)
Mar 2018
-
-$2.37 M(-704.1%)
-$5.90 M(-19.3%)
Dec 2017
-$7.31 M(-33.4%)
$392.00 K(-118.1%)
-$7.31 M(-24.9%)
Sep 2017
-
-$2.17 M(+23.4%)
-$9.73 M(+1.1%)
Jun 2017
-
-$1.76 M(-53.5%)
-$9.63 M(-4.8%)
Mar 2017
-
-$3.78 M(+86.1%)
-$10.11 M(-8.0%)
Dec 2016
-$10.98 M(-48.0%)
-$2.03 M(-1.5%)
-$10.98 M(-27.8%)
Sep 2016
-
-$2.06 M(-8.0%)
-$15.22 M(-17.8%)
Jun 2016
-
-$2.24 M(-51.8%)
-$18.51 M(-12.4%)
Mar 2016
-
-$4.65 M(-25.8%)
-$21.13 M(-0.0%)
Dec 2015
-$21.14 M
-$6.27 M(+17.2%)
-$21.14 M(+6.8%)
Sep 2015
-
-$5.35 M(+10.1%)
-$19.80 M(+6.7%)
DateAnnualQuarterlyTTM
Jun 2015
-
-$4.86 M(+4.2%)
-$18.56 M(+6.1%)
Mar 2015
-
-$4.66 M(-5.4%)
-$17.49 M(+3.4%)
Dec 2014
-$16.90 M(+9.2%)
-$4.93 M(+19.8%)
-$16.90 M(+0.4%)
Sep 2014
-
-$4.11 M(+8.6%)
-$16.84 M(+7.2%)
Jun 2014
-
-$3.79 M(-7.2%)
-$15.71 M(-2.3%)
Mar 2014
-
-$4.08 M(-16.2%)
-$16.08 M(+3.8%)
Dec 2013
-$15.49 M(+86.4%)
-$4.87 M(+63.2%)
-$15.48 M(+15.0%)
Sep 2013
-
-$2.98 M(-28.1%)
-$13.46 M(+27.2%)
Jun 2013
-
-$4.15 M(+19.0%)
-$10.59 M(+13.7%)
Mar 2013
-
-$3.49 M(+22.7%)
-$9.31 M(+12.1%)
Dec 2012
-$8.31 M(+92.3%)
-$2.84 M(+2581.1%)
-$8.31 M(+4.7%)
Sep 2012
-
-$106.00 K(-96.3%)
-$7.93 M(-3.0%)
Jun 2012
-
-$2.88 M(+15.7%)
-$8.18 M(+68.2%)
Mar 2012
-
-$2.48 M(+0.7%)
-$4.86 M(+12.5%)
Dec 2011
-$4.32 M(-4.3%)
-$2.47 M(+609.2%)
-$4.32 M(+125.9%)
Sep 2011
-
-$348.00 K(-179.1%)
-$1.91 M(-40.4%)
Jun 2011
-
$440.00 K(-122.6%)
-$3.21 M(-33.7%)
Mar 2011
-
-$1.95 M(+3141.7%)
-$4.84 M(+7.2%)
Dec 2010
-$4.52 M(-264.8%)
-$60.00 K(-96.4%)
-$4.52 M(+342.3%)
Sep 2010
-
-$1.65 M(+38.1%)
-$1.02 M(-290.5%)
Jun 2010
-
-$1.19 M(-26.3%)
$536.00 K(-63.0%)
Mar 2010
-
-$1.62 M(-147.1%)
$1.45 M(-47.1%)
Dec 2009
$2.74 M(-132.2%)
$3.44 M(-3959.6%)
$2.74 M(-219.3%)
Sep 2009
-
-$89.00 K(-68.0%)
-$2.29 M(-39.2%)
Jun 2009
-
-$278.00 K(-15.5%)
-$3.77 M(-37.1%)
Mar 2009
-
-$329.00 K(-79.4%)
-$6.00 M(-29.5%)
Dec 2008
-$8.51 M(+44.8%)
-$1.60 M(+2.1%)
-$8.51 M(+0.4%)
Sep 2008
-
-$1.57 M(-37.5%)
-$8.47 M(-0.7%)
Jun 2008
-
-$2.50 M(-11.8%)
-$8.53 M(+10.8%)
Mar 2008
-
-$2.84 M(+81.6%)
-$7.70 M(+31.0%)
Dec 2007
-$5.88 M(+6.3%)
-$1.56 M(-4.0%)
-$5.88 M(-41.5%)
Sep 2007
-
-$1.63 M(-2.5%)
-$10.05 M(+22.4%)
Jun 2007
-
-$1.67 M(+64.5%)
-$8.21 M(+25.5%)
Mar 2007
-
-$1.01 M(-82.3%)
-$6.54 M(+18.4%)
Dec 2006
-$5.53 M(+54.8%)
-$5.73 M(-2856.7%)
-$5.53 M(-2756.7%)
Sep 2006
-
$208.00 K
$208.00 K
Dec 2005
-$3.57 M(+274.5%)
-
-
Dec 2003
-$953.00 K
-
-

FAQ

  • What is NovaBay Pharmaceuticals annual operating income?
  • What is the all time high annual operating profit for NovaBay Pharmaceuticals?
  • What is NovaBay Pharmaceuticals annual operating profit year-on-year change?
  • What is NovaBay Pharmaceuticals quarterly operating income?
  • What is the all time high quarterly operating profit for NovaBay Pharmaceuticals?
  • What is NovaBay Pharmaceuticals quarterly operating profit year-on-year change?
  • What is NovaBay Pharmaceuticals TTM operating income?
  • What is the all time high TTM operating profit for NovaBay Pharmaceuticals?
  • What is NovaBay Pharmaceuticals TTM operating profit year-on-year change?

What is NovaBay Pharmaceuticals annual operating income?

The current annual operating profit of NBY is -$5.00 M

What is the all time high annual operating profit for NovaBay Pharmaceuticals?

NovaBay Pharmaceuticals all-time high annual operating income is $2.74 M

What is NovaBay Pharmaceuticals annual operating profit year-on-year change?

Over the past year, NBY annual operating income has changed by +$2.68 M (+34.86%)

What is NovaBay Pharmaceuticals quarterly operating income?

The current quarterly operating profit of NBY is -$1.06 M

What is the all time high quarterly operating profit for NovaBay Pharmaceuticals?

NovaBay Pharmaceuticals all-time high quarterly operating income is $3.44 M

What is NovaBay Pharmaceuticals quarterly operating profit year-on-year change?

Over the past year, NBY quarterly operating income has changed by -$363.00 K (-52.01%)

What is NovaBay Pharmaceuticals TTM operating income?

The current TTM operating profit of NBY is -$5.59 M

What is the all time high TTM operating profit for NovaBay Pharmaceuticals?

NovaBay Pharmaceuticals all-time high TTM operating income is $2.74 M

What is NovaBay Pharmaceuticals TTM operating profit year-on-year change?

Over the past year, NBY TTM operating income has changed by +$189.00 K (+3.27%)